Skin assessment
- Medical questionnaire and photo review
- Personalized treatment plan
- Prescription when appropriate
CA$175
per consultation
Modern Dermatology
Cibinqo
Abrocitinib
Prescription only
Cibinqo assessed online(Abrocitinib)
Cibinqo is an oral medicine for eczema that topical care has not controlled. Your clinician first checks if online care is suitable for you. Some patients need in-person care or specialist monitoring.
Start my assessmentAt a glance
- Oral prescription (abrocitinib)
- For moderate to severe eczema
- Needs checks before and during use
Why Modern Dermatology
- Canadian-licensed medical professionals, 100% online
- Prescriptions sent to your pharmacy or delivered
- Follow-up and refills through your Care Team
Used forEczemaAtopic dermatitis
Cibinqo can raise the risk of serious infections, blood clots, heart problems and some cancers. Report fever, chest pain, shortness of breath or a swollen leg to a doctor right away. Do not stop or restart it on your own.
Choosing the right dose for you
Your clinician chooses the dose from your eczema, your health and your test results. The dose can change over time. Never change the dose on your own.
Considerations include
- How severe and widespread your eczema is
- Past treatments and how they worked
- Your age and overall health
- Your blood test results
- Other medicines you take
How Cibinqo works
Cibinqo calms the signals that drive eczema
Eczema is driven by overactive immune signals in the skin. These signals cause itch, redness and a damaged skin barrier. Cibinqo blocks an enzyme called JAK1, which passes some of those signals along.
With the signals lowered, itch and rash can ease. You still need a gentle skin routine and, when advised, a topical treatment.
Modern Dermatology
Cibinqo
Abrocitinib
Prescription only
Recommended for
- Moderate to severe eczema
- Eczema not controlled by topical care
- Itch that disturbs daily life or sleep
- Adults who want an oral option
- People who can attend regular follow-up
Your clinician reviews your skin and history, and confirms that this treatment is right for you before prescribing.
Blocks JAK1 signals
Calms immune activity in skin
Eases itch
Less scratching, better sleep
Reduces redness
Rash can settle over weeks
Works from inside
A tablet, not a cream
How it works.
- 01
Tell us about your skin
Complete a quick medical questionnaire and upload a few photos of your skin concerns. No appointment needed.
- 02
Get your personalized treatment plan
A Canadian-licensed medical professional will review your information and recommend a personalized treatment plan, including prescriptions when appropriate. Most conditions can be assessed without a video consultation.
- 03
Start your treatment
Get your prescribed medications delivered right to your door. Medication costs are billed separately from your consultation.
- 04
Follow up on your progress
At a follow-up, your clinician can review your progress, discuss side effects and adjust your treatment if needed.
Clear answers.
Have more questions? See our full FAQ or Contact us.
Still have questions? Reach our care team at 514 111 1111
Start my assessmentCibinqo blocks JAK1, an enzyme that helps pass inflammatory signals in the skin. This lowers itch and redness. It works inside the body, so it is different from a cream.
Some people feel less itch within the first weeks. Skin often keeps improving over the following weeks. Your clinician checks your response at follow-up and decides whether to continue.
Many people have less itch and clearer skin, but results vary. Cibinqo does not cure eczema. Your clinician sets goals with you and reviews them over time.
Yes, when it is appropriate for you. A Canadian-licensed medical professional reviews your online intake. Your clinician decides if Cibinqo is right for you. Your clinician first checks if online care is suitable, and some patients need in-person care or specialist monitoring.
Common effects are nausea, headache, dizziness, acne and cold-like symptoms. Cold sores can return. Serious but less common risks include serious infection and blood clots, so tell your Care Team about new symptoms.
People with an active serious infection, including tuberculosis, should not take it. Your clinician takes extra care if you have a history of clots, heart disease, cancer, liver problems or if you smoke. Tell us about all of your medicines.
Options include topical steroids such as amcinonide, betamethasone dipropionate, betamethasone valerate, fluocinonide, desonide and hydrocortisone, plus crisaborole, fusidic acid, cyclosporine and dupilumab. Your clinician explains which fit you.
Often yes. Moisturizers and gentle cleansers are part of good care, and a topical treatment may stay in your plan. Do not mix in other medicines without telling your clinician. Avoid live vaccines.
Tell your clinician if you are pregnant, plan to become pregnant or breastfeed. Your clinician decides if Cibinqo is suitable and may advise on contraception.
Cibinqo is the brand name in Canada, and no other brand names are listed for abrocitinib at this time. Your pharmacist can tell you if a generic is available.
Each consultation costs CA$175. Your pharmacy charges separately for medication. Ask your insurer whether your plan covers the prescribed treatment.
Your clinician sets how long a prescription lasts and when to check in. Your Care Team arranges follow-up and renewals when appropriate. Do not stop or change Cibinqo on your own.
Checked carefully, before and during treatment
Infection screening
Your clinician checks for tuberculosis and other infections before you start.
Blood tests
Blood counts and fats in the blood are tested as your clinician advises.
Clot and heart review
You review clot, heart and smoking history before and during treatment.
Skin and symptom checks
Photos and follow-up show if it works and if it is safe to continue.
Simple pricing for your skin care.
Medication costs are separate. Ask your insurer whether your plan reimburses online consultations.
Start my assessment
Related treatments
Your clinician can suggest another option when this one is not the right fit.